Fever screening systems market seen topping $3.48 billion by 2030

By AI, Created 5:01 PM UTC, May 18, 2026, /AGP/ – The Business Research Company says the fever screening systems market will grow from $2.47 billion in 2026 to $3.48 billion by 2030 as demand rises for rapid, contactless temperature checks in healthcare, workplaces and crowded public spaces. The report points to infectious disease concerns, preventive care spending and healthcare infrastructure investment as the main growth drivers.

Why it matters: - Fever screening systems are becoming a standard front-line tool for quick temperature checks in clinical and public settings. - The market is being shaped by higher concern over infectious disease spread and the push for faster early detection. - The report frames the category as a beneficiary of broader spending on preventive care, smart healthcare infrastructure and workplace safety.

What happened: - The Business Research Company published a fever screening systems market report on May 15, 2026. - The report puts the market at $2.27 billion in 2025 and $2.47 billion in 2026. - The report forecasts the market will reach $3.48 billion by 2030. - The report says the market will grow at an 8.8% CAGR from 2025 to 2026 and a 9.0% CAGR through 2030. - North America led the market in 2025. - Asia-Pacific is forecast to be the fastest-growing region.

The details: - Fever screening systems use non-contact infrared or thermal sensors to measure body temperature, usually on the face or forehead. - The systems are designed for rapid, large-scale screening in clinical or public environments. - The devices flag readings above preset thresholds to help identify potential fever cases early. - Confirmatory medical evaluation usually follows a screening result. - Growth in 2026 is tied to global infectious disease outbreaks, stronger public health monitoring, wider awareness of infection prevention, use of infrared thermography devices and government temperature-check rules. - Growth through 2030 is linked to investment in smart healthcare infrastructure, integration with access control systems, demand for real-time monitoring, AI-powered anomaly detection and workplace health standards. - Key trends include contactless temperature screening, use in crowded public spaces, portable devices, automated alerts and multi-person thermal scanning. - Infectious diseases caused by bacteria, viruses, fungi and parasites are a core demand driver. - Urbanization and global travel are increasing the need for early detection tools. - The UK Health Security Agency reported in June 2024 that 1,681 patients were admitted to critical care with confirmed influenza between week 40 of 2022 and week 15 of 2023. - Preventive care made up 3.7% of total healthcare spending in the EU in 2023, according to Eurostat in October 2025. - The Netherlands led the EU in preventive care spending at 5.2%, while Malta was lowest at 0.9%. - In May 2023, the UK Department of Health and Social Care announced a $27.02 billion (£20 billion) funding package for hospital infrastructure development. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market forecast reflects a broader shift toward prevention, not just treatment, across healthcare systems. - Fever screening remains a screening layer, not a diagnostic one, which limits the technology to triage and monitoring use cases. - The regional growth split suggests mature demand in North America and faster adoption in Asia-Pacific as public health and infrastructure spending expands.

What’s next: - Demand will likely track investment in automated screening, access control integration and AI-based detection tools. - Adoption should stay strongest where governments, hospitals and employers want faster throughput and lower transmission risk. - The market will also be shaped by how widely portable and multi-person screening systems replace manual checks.

The bottom line: - Fever screening systems are moving from emergency-era use toward a broader preventive health market, with growth driven by disease monitoring, infrastructure upgrades and contactless automation.